NCT01815203View on ClinicalTrials.gov

Caffein Consumption and Response Inhibition

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
Eating BehaviorObesity
Interventions
DRUG

Caffeine

Administration of one gelatin capsule containing 200-300 mg of caffeine with subsequent cognitive tasks and food test.

DRUG

Placebo

Administration of placebo with subsequent cognitive tasks and food test.

Trial Locations (1)

75319

Uppsala University, Uppsala

All Listed Sponsors
lead

Uppsala University

OTHER

NCT01815203 - Caffein Consumption and Response Inhibition | Biotech Hunter | Biotech Hunter